Skip to content

WOMAN Trial

Around the world, one woman dies every five minutes from excessive bleeding after giving birth, a medical complication known as postpartum haemorrhage. The majority of these women live in low- and middle-income countries where access to life-saving emergency healthcare is often limited. 

The WOMAN trial tested whether tranexamic acid, a blood clot stabiliser discovered in Japan in the 1950s, could become an essential tool for fighting postpartum haemorrhage. The trial has been an international collaboration of researchers, clinicians and healthcare professionals in 21 countries coordinated by the Clinical Trials Unit at the London School of Hygiene & Tropical Medicine and the trial reached the end of recruitment in April 2016 having enrolled 20, 060 women. The results of this trial are now available and published as of April 2017 in the Lancet bit.ly/2pj35h5

STATUS

Publication and dissemination

START DATE

1 May 2009

END DATE

12 May 2016

PATIENTS RECRUITED

20,060

FUNDERS
Bill & Melinda Gates Foundation Department of Health Wellcome Trust